Tag Archives: meta analyses

Register Now for “Systematic Review and Meta-Analysis for Research: Your Checklist for Success”

Posted on by

Join us and discover the value of systematic reviews and key statistical concepts for meta-analysis success. Presentations will focus on the differences between a systematic review and meta-analysis, Wiley’s Cochrane Library and their gold standards for conducting a systematic review, and how meta-analysis can summarize and quantify the results pulled from identified studies.  

You’ll also have an opportunity to pose questions to our expert speakers and dive deeper into these research methodologies.  

Date: Thursday, June 16, 2022
Time: 12:00 PM to 1:30 PM, EST
Location – Zoom Webinar – Register Now

Speakers

Colleen Finley, Product Manager, Cochrane Library, Wiley
With over 35 years of experience in publishing, Colleen has an extensive background in product management for digital platforms, with emphasis on database creation and search. As a Product Manager for Wiley Online Library and Cochrane Library search, she evaluates user needs and creates requirements for new features. Prior to joining Wiley, Colleen worked at Elsevier as Online Product manager for Embase.

Celine Soudant, MAgrSc, MLIS, Research Informationist II, MSK Library
Celine Soudant joined the MSK Library in 2019 as a Research Informationist and liaison to the nursing community. Celine assists users with literature searches and offers workshops such as conducting a literature search, introduction to systematic reviews, and understanding reference management tools. In addition, as a member of MSK Library’s Systematic Review Service, she supports teams undertaking systematic reviews. Celine holds a Master of Library and Information Science (Palmer School of Library and Information Science, LIU, New York) and a Master of Science in Agriculture (Ecole supérieure d’Agriculture d’Angers, France).

Andrew Vickers, PhD, Attending Research Methodologist, Epidemiology & Biostatistics, MSK
Dr. Vickers’ research falls into three broad areas: randomized trials, surgical outcomes research and molecular marker studies. A particular focus of his work is the detection and initial treatment of prostate cancer. Dr Vickers has analyzed the ’learning curve’ for radical prostatectomy. He is working on a series of studies demonstrating that a single measure of prostate specific antigen (PSA) taken in middle age can predict lethal prostate cancer up to 30 years subsequently. He has also developed a statistical model to predict the result of prostate biopsy, work that has been commercialized and is clinically available through OPKO Diagnostics. His work on randomized trials focuses on methods for integrating randomized trials into routine surgical practice so as to compare different approaches to surgery. As part of this work he has pioneered the use of web-interfaces for obtaining quality of life data from patients recovering from radical prostatectomy. Dr. Vickers’ methodological research centers primarily on novel methods for assessing the clinical value of predictive tools. In particular, he has developed decision-analytic tools that can be directly applied to a data set, without the need for data gathering on patient preferences or utilities. Dr Vickers has a strong interest in teaching statistics. He is course leader for the MSK biostatistics course and is author of the introductory textbook “What is a p-value anyway?” In his capacity as Co-Director of the PRO-CEL Core Facility, Dr. Vickers spearheads a number of innovative informatics initiatives throughout MSK, including the Amplio quality assurance system. He attended his first Cochrane Collaboration meeting in 1995 and has worked on systematic reviews since 1994. 

PRISMA-S Extension for Reporting Literature Searches

Posted on by

First introduced in 2009, the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement provides guidance to authors, journal editors, and readers about which informational elements should ideally be reported on and in what detail in a systematic review (SR) publication.

With the increase in systematic review publications over the last decade came more variance and variety within the SR/evidence synthesis study design, prompting the need for even more specialized guidance. Responding to this need, various special interest PRISMA groups worked to develop “extensions” to the PRISMA reporting guidelines, their number now reaching ten.

From the Equator Network:

PRISMA-Equity: Welch V, Petticrew M, Tugwell P, Moher D, O’Neill J, Waters E, White H; PRISMA-Equity Bellagio group. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity. PLoS Med. 2012;9(10):e1001333. PMID: 23222917

PRISMA-Abstracts: Beller EM, Glasziou PP, Altman DG, Hopewell S, Bastian H, Chalmers I, Gøtzsche PC, Lasserson T, Tovey D; PRISMA for Abstracts Group. PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts. PLoS Med. 2013;10(4):e1001419. PMID: 23585737

PRISMA-P: Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. PMID: 25554246

PRISMA-IPD: Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF; PRISMA-IPD Development Group. Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement. JAMA. 2015;313(16):1657-1665. PMID: 25919529

PRISMA extension for network meta-analyses: Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations. Ann Intern Med. 2015;162(11):777-784. PMID: 26030634

PRISMA-harms: Zorzela L, Loke YK, Ioannidis JP, Golder S, Santaguida P, Altman DG, Moher D, Vohra S; PRISMA harms group. PRISMA harms checklist: improving harms reporting in systematic reviews. BMJ. 2016;352:i157. PMID: 26830668

PRISMA-CI: Guise JM, Butler ME, Chang C, Viswanathan M, Pigott T, Tugwell P; Complex Interventions Workgroup. AHRQ Series on Complex Intervention Systematic Reviews – Paper 6: PRISMA-CI Extension Statement & Checklist. J Clin Epidemiol. 2017. PMID: 28720516

PRISMA-DTA: McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM; and the PRISMA-DTA Group. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA. 2018;319(4):388-396. PMID: 29362800

PRISMA-ScR: Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018. PMID: 30178033

The latest PRISMA extension to be published in 2021 is the PRISMA-S extension which provides detailed guidance related to the preferred reporting of SR literature searches.

Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, Koffel JB; PRISMA-S Group. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. 2021 Jan 26;10(1):39. doi: 10.1186/s13643-020-01542-z. PMID: 33499930; PMCID: PMC7839230.

To learn more about best practices regarding the literature search required – and its reporting – for a systematic review, be sure to check out the MSK Library’s Systematic Review Service LibGuide and/or consider attending an upcoming training class.